Details for New Drug Application (NDA): 209506
✉ Email this page to a colleague
The generic ingredient in DAPSONE is dapsone. There are eight drug master file entries for this compound. Thirty suppliers are listed for this compound. Additional details are available on the dapsone profile page.
Summary for 209506
| Tradename: | DAPSONE |
| Applicant: | Sun Pharma Canada |
| Ingredient: | dapsone |
| Patents: | 0 |
Suppliers and Packaging for NDA: 209506
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| DAPSONE | dapsone | GEL;TOPICAL | 209506 | ANDA | NORTHSTAR RX LLC | 16714-956 | 16714-956-01 | 1 TUBE in 1 CARTON (16714-956-01) / 60 g in 1 TUBE |
| DAPSONE | dapsone | GEL;TOPICAL | 209506 | ANDA | NORTHSTAR RX LLC | 16714-956 | 16714-956-02 | 1 TUBE in 1 CARTON (16714-956-02) / 90 g in 1 TUBE |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | GEL;TOPICAL | Strength | 5% | ||||
| Approval Date: | Oct 16, 2017 | TE: | AB | RLD: | No | ||||
Complete Access Available with Subscription
